Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Will Feuer Arbutus Biopharma Corp. and its licensee Genevant Sciences have filed a patent-infringement lawsuit against Pfizer Inc. and BioNTech SE related to the latter's Covid-19 vaccine.... | April 4, 2023
BioNTech receives exclusive licenses from DualityBio for two investigational antibody-drug conjugate assets directed against targets expressed in a broad range of human cancersCollaboration will add... | April 3, 2023
By Chris Wack Biopharmaceutical companies BioNTech SE and Duality Biologics Co. Ltd. have entered into exclusive license and collaboration agreements to develop, manufacture and commercialize... | April 3, 2023
Germany's BioNTech said on Monday that it signed a deal with Chinese biotech company DualityBio to co-develop and commercialize two cancer antibody drug candidates. DualityBio will... | April 3, 2023
BioNTech and Duality Biologics have entered into exclusive license and collaboration agreements for two ADC assets: thus adding ADCs as an additional drug class in BioNTech’s oncology portfolio.